EMFO LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

EMFO LLC’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$62.8K	Hold	134	–	–	0.06%	141
2024 Q1	$56K	Hold	134	–	–	0.05%	151
2023 Q4	$54.5K	Sell	134 -120	-47%	-$44.3K	0.05%	151
2023 Q3	$88.3K	Hold	254	–	–	0.08%	132
2023 Q2	$89.4K	Hold	254	–	–	0.08%	138
2023 Q1	$80K	Hold	254	–	–	0.08%	144
2022 Q4	$73.3K	Hold	254	–	–	0.07%	142
2022 Q3	$74K	Buy	254 +34	+15%	+$9.78K	0.07%	156
2022 Q2	$62K	Hold	220	–	–	0.06%	166
2022 Q1	$57K	Hold	220	–	–	0.05%	186
2021 Q4	$48K	Hold	220	–	–	0.04%	202
2021 Q3	$40K	Hold	220	–	–	0.04%	222
2021 Q2	$44K	Buy	+220	New	+$46K	0.04%	211

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

EMFO LLC's VRTX Position: Q2 2024 in Review

EMFO LLC held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2024 at 134 shares worth $62.8K. The position accounts for 0.06% of the portfolio, ranked #141.

EMFO LLC first reported a position in VRTX in Q2 2021 and has held it in 13 quarters since. The position peaked at $89.4K in Q2 2023. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

EMFO LLC held 134 shares of Vertex Pharmaceuticals worth $62.8K as of Q2 2024.
EMFO LLC left its Vertex Pharmaceuticals share count unchanged in Q2 2024.
Vertex Pharmaceuticals made up 0.06% of EMFO LLC's portfolio in Q2 2024, its #141 holding.
EMFO LLC first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 13 quarters since.
EMFO LLC's Vertex Pharmaceuticals position peaked at $89.4K in Q2 2023.
1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.